4.8k total citations 49 papers, 3.8k citations indexed
About
Harriet M. Bryson is a scholar working on Pharmacology, Epidemiology and Molecular Medicine.
According to data from OpenAlex, Harriet M. Bryson has authored 49 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Epidemiology and 10 papers in Molecular Medicine. Recurrent topics in Harriet M. Bryson's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (4 papers). Harriet M. Bryson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (4 papers). Harriet M. Bryson collaborates with scholars based in New Zealand. Harriet M. Bryson's co-authors include Antona J. Wagstaff, Rick Davis, Bret Fulton, Diana Faulds, Rex N. Brogden, Julia A. Balfour, Paul Benfield, Anthony Markham, Karen L. Goa and Michelle I. Wilde and has published in prestigious journals such as Drugs, CNS Drugs and PharmacoEconomics.
In The Last Decade
Harriet M. Bryson
49 papers
receiving
3.5k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Harriet M. Bryson
Since
Specialization
Citations
This map shows the geographic impact of Harriet M. Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet M. Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet M. Bryson more than expected).
Fields of papers citing papers by Harriet M. Bryson
This network shows the impact of papers produced by Harriet M. Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet M. Bryson. The network helps show where Harriet M. Bryson may publish in the future.
Co-authorship network of co-authors of Harriet M. Bryson
This figure shows the co-authorship network connecting the top 25 collaborators of Harriet M. Bryson.
A scholar is included among the top collaborators of Harriet M. Bryson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Harriet M. Bryson. Harriet M. Bryson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Wagstaff, Antona J. & Harriet M. Bryson. (1997). Tizanidine. Drugs. 53(3). 435–452.159 indexed citations
2.
Patel, Sanjay S., Julia A. Balfour, & Harriet M. Bryson. (1997). Fosfomycin Tromethamine. Drugs. 53(4). 637–656.206 indexed citations
Barradell, Lee B. & Harriet M. Bryson. (1994). Cefepime. Drugs. 47(3). 471–505.135 indexed citations
17.
Davis, Rick & Harriet M. Bryson. (1994). Levofloxacin. Drugs. 47(4). 677–700.286 indexed citations
18.
Bryson, Harriet M. & Eugene M. Sorkin. (1994). Dornase Alfa. Drugs. 48(6). 894–906.28 indexed citations
19.
Bryson, Harriet M. & Greg L. Plosker. (1993). Tamoxifen. PharmacoEconomics. 4(1). 40–66.9 indexed citations
20.
Bryson, Harriet M. & Eugene M. Sorkin. (1993). Cladribine. Drugs. 46(5). 872–894.83 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.